{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:40:29Z","timestamp":1790746829035,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10875-021-00994-9","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T11:03:26Z","timestamp":1613991806000},"page":"536-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-4320","authenticated-orcid":false,"given":"Nicolas","family":"de Prost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Arrestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slim","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Mah\u00e9vas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Burrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Dorgham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gorochov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Tandjaoui-Lambiotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iname","family":"Azzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mekontso-Dessap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Edouard","family":"Luyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585.","journal-title":"Science."},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570.","journal-title":"Science."},{"key":"994_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.medj.2020.12.001","volume":"1","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Bolze A, Jouanguy E, Zhang S-Y. COVID Human Genetic Effort, et al. Life-threatening COVID-19: defective interferons unleash excessive inflammation. Med. 2020;1:14\u201320.","journal-title":"Med"},{"key":"994_CR4","doi-asserted-by":"crossref","unstructured":"Levy R, Bastard P, Lanternier F, Lecuit M, Zhang S-Y, Casanova J-L. IFN-a2a therapy in two patients with inborn errors of TLR3 and IRF3 infected with SARS-CoV-2. J Clin Immunol. 2020; in press.","DOI":"10.1007\/s10875-020-00933-0"},{"key":"994_CR5","unstructured":"WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo A-M, Preziosi M-P, Sathiyamoorthy V, et al. N Engl J Med. 2020; in press."},{"key":"994_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13054-020-03171-3","volume":"24","author":"C Morath","year":"2020","unstructured":"Morath C, Ma W, Zeier M, Speer C, Tiwari-Heckler S, Merle U. Plasma exchange in critically ill COVID-19 patients. Crit Care. 2020;24:481.","journal-title":"Crit Care"},{"key":"994_CR7","doi-asserted-by":"publisher","first-page":"106188","DOI":"10.1016\/j.rmed.2020.106188","volume":"175","author":"WL Gluck","year":"2020","unstructured":"Gluck WL, Callahan SP, Brevetta RA, Stenbit AE, Smith WM, Martin JC, et al. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19. Respir Med. 2020;175:106188.","journal-title":"Respir Med"},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijid.2020.06.064","volume":"99","author":"F Khamis","year":"2020","unstructured":"Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, et al. Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis. 2020;99:214\u20138.","journal-title":"Int J Infect Dis"},{"key":"994_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000223","volume":"2","author":"PD Keith","year":"2020","unstructured":"Keith PD, Scott LK, Weaver KE, Day M, Choe C, Perkins L, et al. Treatment of critically ill coronavirus disease 2019 patients with adjunct therapeutic plasma exchange: a single-center retrospective case series. Crit Care Explor. 2020;2:e0223.","journal-title":"Crit Care Explor"},{"key":"994_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13054-020-03070-7","volume":"24","author":"K Stahl","year":"2020","unstructured":"Stahl K, Bode C, David S. First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19. Crit Care. 2020;24:363.","journal-title":"Crit Care"},{"key":"994_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1473-3099(20)30200-0","volume":"20","author":"F-X Lescure","year":"2020","unstructured":"Lescure F-X, Bouadma L, Nguyen D, Parisey M, Wicky P-H, Behillil S, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020;20:697\u2013706.","journal-title":"Lancet Infect Dis"},{"key":"994_CR12","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. 2020; in press."},{"key":"994_CR13","doi-asserted-by":"crossref","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25.","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010;28:595\u20139.","journal-title":"Nat Biotechnol"},{"key":"994_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/art.40792","volume":"71","author":"A Mathian","year":"2019","unstructured":"Mathian A, Mouries-Martin S, Dorgham K, Devilliers H, Barnabei L, Ben Salah E, et al. Monitoring disease activity in systemic lupus erythematosus with single-molecule array digital enzyme-linked immunosorbent assay quantification of serum interferon-\u03b1. Arthritis Rheumatol. 2019;71:756\u201365.","journal-title":"Arthritis Rheumatol"},{"key":"994_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00134-020-06157-5","volume":"46","author":"S Fourati","year":"2020","unstructured":"Fourati S, Hue S, Pawlotsky J-M, Mekontso-Dessap A, de Prost N. SARS-CoV-2 viral loads and serum IgA\/IgG immune responses in critically ill COVID-19 patients. Intensive Care Med. 2020;46:1781\u20133.","journal-title":"Intensive Care Med"},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s13054-020-03359-7","volume":"24","author":"C Desnos","year":"2020","unstructured":"Desnos C, Boussouar S, Hekimian G, Redheuil A, Combes A. Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms. Crit Care. 2020;24:638.","journal-title":"Crit Care"},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","volume":"383","author":"L Bowles","year":"2020","unstructured":"Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, et al. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med. 2020;383:288\u201390.","journal-title":"N Engl J Med"},{"key":"994_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","volume":"47","author":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators","year":"2020","unstructured":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2020;47:60\u201373.","journal-title":"Intensive Care Med"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-00994-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-021-00994-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-00994-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T22:37:50Z","timestamp":1614638270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-021-00994-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-00994-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NDP, PB, RA, SF, MM, SB, KD, GG, YTL, IA, IF, and JLC have no conflict of interest to disclose; AC reports grants and personal fees from GETINGE, personal fees from BAXTER, and personal fees from XENIOS, outside the submitted work; CEL reports personal fees from Bayer Healthcare, personal fees from Merck, personal fees from Biom\u00e9rieux, personal fees from Carmat, personal fees from Thermofischer Brahms, and personal fees from Aerogen, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All subjects were recruited according to protocols approved by the competent local institutional review boards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All protocols conformed to local ethics recommendations and informed consent was obtained when required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Included subjects were informed and consented for the publication when feasible.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}